This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Well Characterized Biologics & Biological Assays

Savings Deadline Ends In:

  • 00
  • 00
  • 00
  • 00
November 1-3, 2022
College Park Marriott Hotel & Conference CenterHyattsville, Maryland, USA

Greg Adams
Senior Director, Global Analytical Strategy & Development at FUJIFILM Diosynth Biotechnologies


Greg has 30 years of experience in analytical development, specializing in the mass spectrometric characterization of protein based biopharmaceuticals. He received his doctorate from the University of Adelaide followed by postdoctoral research at the University of California, San Francisco. For the past twenty years, he has worked at FUJIFILM Diosynth Biotechnologies in analytical development supporting the characterization and method development of biotherapeutic proteins in clinical development and commercial production.

Agenda Sessions

  • Phase Appropriate Method Validation and Leveraging Platform Data